Efficacy and Safety Study of Pegylated Interferon Lambda-1a With Ribavirin and Daclatasvir, to Treat naïve Subjects With Chronic HCV Genotypes 1, 2, 3, and 4 Who Are Co-infected With HIV
Clinical trial NCT01866930 · TERMINATED
Trial details
- NCT number
- NCT01866930
- Sponsor
- Bristol-Myers Squibb
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-07-11
- Primary completion
- 2015-08-27
- Enrollment
- 453
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.